Pharma groups to profit from virus?

Pharma groups to profit from virus?

The top 10 global pharmaceutical companies are being scrutinised and advised not to prevent or delay a vaccine for COVID-19 from reaching vulnerable people to gain profits, triggering global concerns over their social responsibility.
Multinationals riding high in Vietnam’s pharma landscape

Multinationals riding high in Vietnam’s pharma landscape

Multinational corporations like Sanofi, GlaxoSmithKline, and Reckitt Benckiser gaining the advantage in Vietnam’s over-the-counter channel, or non-description drugs, in the first quarter of 2020 has in part fuelled their global performance.
GlaxoSmithKline seeking to validate EU-GMP standards

GlaxoSmithKline seeking to validate EU-GMP standards

Multinational corporations are rushing to seek official quality standards recognition in order to gain advantages and high profit in tenders of high-cost branded drugs in the lucrative Vietnamese market, but the journey will not be a fruitful one for all.
Drug price hikes in US threaten the same in Vietnam?

Drug price hikes in US threaten the same in Vietnam?

Pfizer, Sanofi, and GlaxoSmithKline are reported to plan increasing drug prices in the US in 2020, triggering public concerns over a similar hike in Vietnam.